Cleared Traditional

K896294 - DSL I-PTH (DSL #8000)

K896294 is the FDA 510(k) clearance for DSL I-PTH (DSL #8000) by Diagnostic Systems Laboratories, Inc.. It is a Class 2 Chemistry device (product code CEW) cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K896294 · Diagnostic Systems Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1989
Decision
21d
Days
Class 2
Risk

K896294 is an FDA 510(k) clearance for the DSL I-PTH (DSL #8000). Classified as Radioimmunoassay, Parathyroid Hormone (product code CEW), Class II - Special Controls.

Submitted by Diagnostic Systems Laboratories, Inc. (Webster, US). The FDA issued a Cleared decision on November 21, 1989 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1545 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Systems Laboratories, Inc. devices

Submission Details

510(k) Number K896294 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 1989
Decision Date November 21, 1989
Days to Decision 21 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 88d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CEW Radioimmunoassay, Parathyroid Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1545
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEW Radioimmunoassay, Parathyroid Hormone

All 50
Devices cleared under the same product code (CEW) and FDA review panel - the closest regulatory comparables to K896294.
N-TACT(R) PTH SP KIT
K921629 · Incstar Corp. · May 1992
VENTREX COATED TUBE INTACT PTH
K913434 · Ventrex Laboratories, Inc. · Oct 1991
PTH-MM II 125I RADIOIMMUNOASSAY (RIA)
K901711 · Incstar Corp. · Jul 1990
CIBA CORNING MAGIC LITE INTACT PTH IMMUNOASSAY
K882560 · Ciba Corning Diagnostics Corp. · Oct 1988
N-TACT PTH BY IMMUNORADIOMETRIC ASSAY (IRMA)
K874299 · Incstar Corp. · Nov 1987
DOUBLE ANTIBODY ULTRA-PTH #KPTD1 AND KPTD2
K871970 · Diagnostic Products Corp. · Sep 1987